OnDemand WTP Pricing Research

Tag: Drug Prices

Trump price transparency proposals take long bet on curbing costs | Modern Healthcare

Trump price transparency proposals take long bet on curbing costs | Modern Healthcare

Requiring hospitals to display their insurer-negotiated prices online likely won’t lower healthcare spending in the near term. But economists and other experts say it’s a worthwhile experiment in bringing transparency to one of the few industries in which patients often don’t know the cost of a service before they buy it. The Trump administration earlier […]

Trump And The Senate Make Significant Progress On Hospital Price Transparency | Forbes

Trump And The Senate Make Significant Progress On Hospital Price Transparency | Forbes

For years, observers from across the spectrum have called for more price transparency in health care, especially when it comes to hospitals. Thanks to initiatives from the White House and a key Senate committee, that moment is now close at hand. Proposed rule could revolutionize hospital markets On July 30, the Centers for Medicare and […]

Pfizer to combine off-patent drug business with Mylan | PHYS.ORG

Pfizer to combine off-patent drug business with Mylan | PHYS.ORG

Pfizer announced Monday it will merge its off-patent drug business with generic drugmaker Mylan to create a global leader in low-cost treatment, a business that faces significant political pressure in the US. The new entity, which will be renamed upon the deal’s closure, will have a portfolio that includes impotence drug Viagra, cholesterol pills Lipitor, […]

Trump proposes hospitals publish prices negotiated with insurers | CNBC

Trump proposes hospitals publish prices negotiated with insurers | CNBC

The Trump administration is proposing a rule that would require hospitals to publish the prices that are negotiated with insurers or risk being fined. The proposed rule, announced Monday, would apply to the roughly 6,000 hospitals that accept Medicare. Hospitals could be fined up to $300 a day if the standard and negotiated prices for […]

Senate Finance drug pricing bill faces opposition in full Senate | Healthcare Finance

Senate Finance drug pricing bill faces opposition in full Senate | Healthcare Finance

The Prescription Drug Pricing Reduction Act that passed in the Senate Finance Committee by a bipartisan vote of 19 to 9 is facing opposition from some Republicans in the full Senate. The bill is scheduled to go before the Senate in the fall, but some GOP senators oppose the legislation as price control. Senate Majority […]

Generics in Media: Pricing Battles and Reputational Challenges | Commetric

Generics in Media: Pricing Battles and Reputational Challenges | Commetric

The notoriously high prices of medicines in the US have sparked off fierce debates among a wide range of stakeholders, including patients, providers, payers, academics and policy makers. The media has got into the habit of reminding us that Americans spend more on prescriptions drugs than the patients in any other developed country – around […]

How 4 healthcare providers will respond to Trump’s price transparency order | Becker’s Hospital Review

How 4 healthcare providers will respond to Trump’s price transparency order | Becker’s Hospital Review

Reaction Data, a an online healthcare research platform based in American Fork, Utah, recently surveyed nearly 300 healthcare leaders about their opinions on the executive order signed by President Donald Trump June 24 related to price disclosure. The executive order aims to lower healthcare costs by improving price transparency. It directs governmental agencies to set rules requiring […]

Grassley Says His Drug Pricing Proposal Would Save The Government $85 Billion In 10 Years | The Daily Caller

Grassley Says His Drug Pricing Proposal Would Save The Government $85 Billion In 10 Years | The Daily Caller

Sens. Chuck Grassley and Ron Wyden rolled out their drug pricing reform package Tuesday, and they say it will save the federal government $85 billion over the next decade by capping drugmakers’ price hikes in Medicare. “Pharmaceutical companies play a vital role in creating new and innovative medicines that save and improve the quality of […]

Heart attack risk rises with price of cholesterol-lowering drug, study says | UPI

Heart attack risk rises with price of cholesterol-lowering drug, study says | UPI

July 23 (UPI) — When insurance companies refuse to cover cholesterol-lowering drugs, it puts patients at risk for stroke and heart ailments, a new study says. Getting rejected for medications these medications puts patients at a 16 percent higher risk of having a heart attack, unstable angina, cardiac arrest or other cardiac events, according to […]

Drugmaker Group Boosts Lobbying as Push to Lower Prices Stalls | Bloomberg

Drugmaker Group Boosts Lobbying as Push to Lower Prices Stalls | Bloomberg

The drug industry’s primary trade group increased its spending on lobbying during the second quarter, as President Donald Trump’s promised efforts to lower the prices of prescription drugs stalled. The Pharmaceutical Research and Manufacturers of America, which represents leading drugmakers, reported spending $6.2 million in the quarter that ended June 30, a 12% increase from […]